Displaying 1801-1850 of 1922 result(s).
Recent Articles
- FLSmidth's Strategic Share Buy-Back Program Explained
- Valmet Appoints Jon Jested-Rask as New Executive Vice President
- Gupshup Secures $60 Million Investment to Elevate AI Capabilities
- Expected Growth in the Marine Lighting Sector to 2032
- Cornish Metals Expands Share Capital with New Stock Options
- Caledonia Mining Reports Improving Profitability in Gold Production
- OSB Group Engages in Robust Share Buyback Strategy
- Foresight Group Completes Significant Share Buyback Program
- RIBER Reports Strong Start to 2025 with Sales Over €40M
- CoinShares Asset Management Achieves Pioneering Regulatory Success
- EXEL Industries Sees Revenue Decline Amid Market Challenges
- Danske Bank's Share Transactions and Management Insights
- Caledonia Mining Corporation's Positive Financial Outlook for 2025
- RIBER Announces Strong Half-Year Financial Performance
- EXEL Industries Faces Revenue Decline Amid Mixed Performance
- Stora Enso's 2025 Half-Year Insights: Navigating Market Challenges
- Stora Enso's Mid-Year Results: Navigating Challenges Ahead
- Stora Enso's 2025 Half-year Results: Key Insights Revealed
- Strong Start for Alstom in FY 2025: Orders and Sales Rise
- KPN Achieves Impressive Growth; Forecast for 2025 Enhanced
- Unlocking Opportunities: Prosafe SE Begins Warrant Subscription
- Ipsen Welcomes New Leadership in Executive Committee Changes
- Corbion Achieves Outstanding Sustainability Ratings from CDP
- Bill Pulte: A Promising Choice for the Federal Reserve Chair
- Hiab Reports Strong Half-Year Performance and Future Outlook
- KPN's Impressive Q2 Performance Promises Strong 2025 Results
- Alstom's Q1 2025/26 Report: Growth and Strong Outlook Ahead
- GE Vernova's Promising Earnings Predictions and Analyst Ratings
- Navigating Market Dynamics: Tech Resilience Unveiled
- Corbion Leads in Sustainability Ratings Following CDP Evaluation
- Latest Amendments to EfTEN United Property Fund Terms Explained
- Roche's Innovative Blood Test Earns CE Mark for Alzheimer’s Diagnosis
- Renault Group Showcases Resilience in Challenging Auto Market
- BAWAG Group's Financial Highlights and Future Outlook
- Hiab's Financial Performance Impresses in 2025 First Half
- Roche's Anticancer Drug Itovebi Gains Approval in Europe
- Equinor’s Robust Q2 2025 Results Highlight Growth and Strategy
- Equinor ASA Announces Upcoming Cash Dividend Details
- Equinor Launches Next Phase of 2025 Share Buy-Back Strategy
- Equinor's Impressive Q2 2025 Financial Achievements Unveiled
- Join Jay's Insightful Journey at CISCE for a Healthier Life
- Akkodis Takes Action for Sustainable Urban Mobility with FEDORA
- Innovative Traffic Management Boosts Sustainable Urban Mobility
- SM Group's Commitment to Cutting Down Plastic Waste Efforts
- SM Investments: Championing Diversity in the Workplace
- The Future of RAN Revenue Forecast and Market Innovations
- PayPal World Launches Global Payment Interoperability Initiative
- Empowering Future Leaders in Hospitality Through Scholarships
- Corporate Insiders Message: A Bearish Sentiment on Stocks
- Countdown to CIFTIS 2025: Key Insights and Opportunities